In preparation for its spin-off from Novartis, Sandoz began building an independent board. Chair-elect Gilbert Ghostine led the effort to define the company’s governance model, identify the mix of skills and values needed, and recruit a diverse, purpose-driven group of directors. Before the official separation, the new directors came together to establish trust, shared understanding, and alignment around Sandoz’s mission. The case examines how to build and prepare an effective board to oversee the company’s transformation into a public entity.
The case study is intended to be used as a basis to address the following issues:
• How to define a collective profile for a future board
• How to supervise the process of recruiting 8 independent board members at the same time
• How to define the new board’s mission and roles
• How to prepare the new board for its debut
- Board of directors
- Corporate governance
- Board formation
- Board composition
- Healthcare industry
- Board effectiveness
- SDG3 Good Health & Well-Being
- SDG12 Responsible Consumption and Production
- Q12026
